Application 214407
- Type
- ANDA
- Sponsor
- L PERRIGO CO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 600MG;60MG | No | No |
| 002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 1.2GM;120MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | ||
| A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 4b0b4de00fa7… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | bb7c543d1eb4… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 1c564ffb4f44… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leader Mucus Relief D | GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE | Cardinal Health 110, LLC. dba Leader | 12971fb2-2314-4443-bf70-b7eb5859b148 | 2026-05-26 | Warnings | 214407 ANDA214407 |
| mucus d | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Kroger Company | 5065f07d-2130-4c84-a64a-dc27ef9cb92e | 2026-04-09 | Warnings | 214407 ANDA214407 |
| nasal and chest decongestant | GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE | Publix Super Markets Inc | 657aeccc-4f6a-496b-9a69-e64a81e4c91e | 2026-04-02 | Warnings | 214407 ANDA214407 |
| equate mucus d | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | WALMART INC. | 0d5f6e14-5e42-494b-be1f-a46731007a0d | 2026-03-19 | Warnings | 214407 ANDA214407 79903-125 |
| mucus d | GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | c8026a56-4249-48de-b763-2d1c55731733 | 2026-02-26 | Warnings | 214407 ANDA214407 |
| mucus relief d | GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE | Walgreen Company | 440c0cf6-d63d-4523-b137-26f70adb977a | 2026-02-07 | Warnings | 214407 ANDA214407 |
| foster and thrive mucus relief d | GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE | Strategic Sourcing Services LLC | 235a465c-3a5e-4775-92e9-e57fd8d9c9b4 | 2026-02-07 | Warnings | 214407 ANDA214407 |
| mucus relief d | GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE | H E B | 80acd350-7c96-4620-bd7c-848c85f157ed | 2026-01-27 | Warnings | 214407 ANDA214407 |
| EQUATE MUCUS D | GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE | WALMART INC. | 1ce50a5b-060d-4fb4-ba91-e62fccf9d5f9 | 2026-01-08 | Warnings | 214407 ANDA214407 |
| Mucus D | GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE | L. Perrigo Company | 86993cd9-5d55-4a70-8a33-701d91482292 | 2025-10-03 | Warnings | 214407 ANDA214407 |
| mucus D | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | L. Perrigo Company | db6ada8a-1799-4d35-8bda-4a322fbd7a06 | 2025-10-03 | Warnings | 214407 ANDA214407 |
| mucus D | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Meijer, Inc. | 5d0c5ded-cf78-4c42-8dc0-8d546884871f | 2025-06-10 | Warnings | 214407 ANDA214407 |
| MUCUS D | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 59bce49c-25c9-4710-a68b-271575ceae2f | 2025-04-16 | Warnings | 214407 ANDA214407 |
| Rugby Mucus Relief D | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Rugby Laboratories | ec947855-d77b-46ad-88bd-cf05b6ff004b | 2025-04-02 | Warnings | 214407 ANDA214407 |
| Leader Mucus Relief D | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Cardinal Health 110, LLC. dba Leader | 919f5bf3-3b51-4450-9496-def940b3cb81 | 2025-03-10 | Warnings | 214407 ANDA214407 |
| Mucus D | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Meijer, Inc. | 4a49c617-79d1-488c-a23f-7103c818b365 | 2025-01-07 | Warnings | 214407 ANDA214407 |
| foster and thrive mucus relief d | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Strategic Sourcing Services LLC | 12460719-ff39-49b3-95f8-85e547ad0076 | 2024-11-21 | Warnings | 214407 ANDA214407 |
| Mucus Relief D | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Walgreen Company | 915ca26a-d5d1-40f8-980d-415926e45656 | 2024-03-30 | Warnings | 214407 ANDA214407 |
| mucus relief d | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | H E B | 0a2a2822-ea30-4a50-ad45-d85fd0431f95 | 2024-01-09 | Warnings | 214407 ANDA214407 |
| topcare mucus d | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Topco Associates LLC | 02134afa-ae8c-4678-a19a-7fd3cab5782f | 2023-08-30 | Warnings | 214407 ANDA214407 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 79903-125 | equate mucus d | guaifenesin and pseudoephedrine hydrochloride | WALMART INC. | ANDA | Current |